Comparison of results of endoscopic correction of vesicoureteral reflux in children using two bulking substances: Dextranomer/hyaluronic acid copolymer (Deflux) versus polyacrylate-polyalcohol copolymer (Vantris)
- PMID: 27593921
- DOI: 10.1016/j.jpurol.2016.04.006
Comparison of results of endoscopic correction of vesicoureteral reflux in children using two bulking substances: Dextranomer/hyaluronic acid copolymer (Deflux) versus polyacrylate-polyalcohol copolymer (Vantris)
Abstract
Background: Endoscopic correction of vesicoureteral reflux (VUR) in children offers minimally invasive management and is widely used as a first-line procedure for all grades of reflux. However, there is debate about which tissue-augmenting substance is the best to use. The aim of this study was to evaluate the efficacy of two bulking substances, Deflux (Dx/HA) and Vantris (PPC), for endoscopic treatment of VUR in children.
Methods: From 2009 to 2012, 65 children (50 girls and 15 boys) aged 1.45-9.9 years (mean 4.85 ± 2.52) underwent endoscopic correction of VUR using Deflux. VUR was unilateral in 31 patients and bilateral in 34 patients, comprising 108 renal refluxing units (RRUs) grades: II in 52, III in 47, IV in 7, and V in 2. From 2012, 68 children (43 girls and 25 boys) aged 0.6-17.9 years (mean 4.89 ± 3.46) were treated with Vantris. VUR was unilateral in 33 and bilateral in 35 patients, comprising 109 RRUs grades: II in 48, III in 29, IV in 13, and V in 19. Voiding cystourethrogram was done 3 months after procedure.
Results: All patients completed follow-up (summary Table). With Deflux, reflux resolved in almost 93% of RRUs after two procedures (in 63% after first injection), with Vantris, VUR was corrected in the same percentage after one procedure.
Discussion: The success rate with Deflux ranges between 68% and 92% (only 50-70% after single injection). The reported possibility of reflux recurrence after successful Deflux treatment, and the need for repeated injection led to introduction of the new substance Vantris. The results of a multi-centre survey published in 2014 showed that reflux is corrected in more than 90% of cases after single PPC injection. Our results with PPC confirm a high level of reflux resolution.
Conclusions: Our data show that Vantris injection is a safe and effective procedure for treating all grades of VUR with good clinical outcome, and provides a higher and almost complete level of reflux resolution after first injection compared with Deflux.
Keywords: Deflux; Endoscopic correction of VUR; Vantris; Vesicoureteral reflux.
Copyright © 2016. Published by Elsevier Ltd.
Similar articles
-
Endoscopic treatment of grades IV and V vesicoureteral reflux with two bulking substances: Dextranomer hyaluronic acid copolymer versus polyacrylate polyalcohol copolymer in children.J Pediatr Surg. 2016 Oct;51(10):1711-5. doi: 10.1016/j.jpedsurg.2016.03.013. Epub 2016 Apr 9. J Pediatr Surg. 2016. PMID: 27117052
-
What are the predictive factors leading to ureteral obstruction following endoscopic correction of VUR in the pediatric population?J Pediatr Urol. 2018 Dec;14(6):538.e1-538.e7. doi: 10.1016/j.jpurol.2018.04.021. Epub 2018 May 25. J Pediatr Urol. 2018. PMID: 29885870
-
Multicenter survey of endoscopic treatment of vesicoureteral reflux using polyacrylate-polyalcohol bulking copolymer (Vantris).Urology. 2014 Sep;84(3):689-93. doi: 10.1016/j.urology.2014.04.033. Urology. 2014. PMID: 25168553
-
Ureteral Obstruction After Endoscopic Treatment of Vesicoureteral Reflux: Does the Type of Injected Bulking Agent Matter?Curr Urol Rep. 2019 Jul 9;20(9):49. doi: 10.1007/s11934-019-0913-5. Curr Urol Rep. 2019. PMID: 31289951 Review.
-
A review of novel STING bulking agents.J Pediatr Urol. 2019 Oct;15(5):484-490. doi: 10.1016/j.jpurol.2019.08.018. Epub 2019 Sep 6. J Pediatr Urol. 2019. PMID: 31591047 Review.
Cited by
-
Macroplastique and Botox are superior to Macroplastique alone in the management of neurogenic vesicoureteric reflux in spinal cord injury population with presumed healthy bladders.J Spinal Cord Med. 2019 Jul;42(4):478-484. doi: 10.1080/10790268.2018.1433266. Epub 2018 Feb 7. J Spinal Cord Med. 2019. PMID: 29412074 Free PMC article.
-
Randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR).World J Urol. 2018 Oct;36(10):1651-1656. doi: 10.1007/s00345-018-2314-7. Epub 2018 May 3. World J Urol. 2018. PMID: 29725806 Clinical Trial.
-
Endoscopic injection of bulking agents in pediatric vesicoureteral reflux: a narrative review of the literature.Pediatr Surg Int. 2023 Feb 18;39(1):133. doi: 10.1007/s00383-023-05426-w. Pediatr Surg Int. 2023. PMID: 36806763 Free PMC article. Review.
-
Idiosyncratic reaction after injection of polyacrylate - polyalcohol copolymer.Int Braz J Urol. 2018 Jul-Aug;44(4):831-834. doi: 10.1590/S1677-5538.IBJU.2017.0446. Int Braz J Urol. 2018. PMID: 29522291 Free PMC article.
-
Endoscopic correction of vesicoureteral reflux in children using polyacrylate-polyalcohol copolymer (Vantris): 5-years of prospective follow-up.Cent European J Urol. 2017;70(3):314-319. doi: 10.5173/ceju.2017.1226. Epub 2017 Jul 24. Cent European J Urol. 2017. PMID: 29104797 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources